GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shenzhen Salubris Pharmaceuticals Co Ltd (SZSE:002294) » Definitions » Dividends per Share

Shenzhenlubris Pharmaceuticals Co (SZSE:002294) Dividends per Share : ¥0.50 (TTM As of Mar. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Shenzhenlubris Pharmaceuticals Co Dividends per Share?

Shenzhenlubris Pharmaceuticals Co's dividends per share for the three months ended in Mar. 2024 was ¥0.00. Its dividends per share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.50. Its Dividend Payout Ratio for the three months ended in Mar. 2024 was 0.00. As of today, Shenzhenlubris Pharmaceuticals Co's Dividend Yield % is 1.83%.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Shenzhen Salubris Pharmaceuticals Co Ltd is 0.91, which seems too high.

Good Sign:

Shenzhen Salubris Pharmaceuticals Co Ltd stock dividend yield is close to 3-year high.

During the past 12 months, Shenzhenlubris Pharmaceuticals Co's average Dividends Per Share Growth Rate was 25.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Shenzhenlubris Pharmaceuticals Co was 75.50% per year. The lowest was -20.60% per year. And the median was 23.10% per year.

For more information regarding to dividend, please check our Dividend Page.


Shenzhenlubris Pharmaceuticals Co Dividends per Share Historical Data

The historical data trend for Shenzhenlubris Pharmaceuticals Co's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhenlubris Pharmaceuticals Co Dividends per Share Chart

Shenzhenlubris Pharmaceuticals Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Dividends per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.80 0.50 - 0.40 0.50

Shenzhenlubris Pharmaceuticals Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Dividends per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.50 - - -

Competitive Comparison of Shenzhenlubris Pharmaceuticals Co's Dividends per Share

For the Medical Instruments & Supplies subindustry, Shenzhenlubris Pharmaceuticals Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shenzhenlubris Pharmaceuticals Co's Dividend Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shenzhenlubris Pharmaceuticals Co's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Shenzhenlubris Pharmaceuticals Co's Dividend Yield % falls into.



Shenzhenlubris Pharmaceuticals Co Dividends per Share Calculation

Dividends paid to per common share.


Shenzhenlubris Pharmaceuticals Co  (SZSE:002294) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Shenzhenlubris Pharmaceuticals Co's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Mar. 2024 )/ EPS without NRI (Q: Mar. 2024 )
=0/ 0.183
=0.00

During the past 13 years, the highest Dividend Payout Ratio of Shenzhenlubris Pharmaceuticals Co was 125.00. The lowest was 0.37. And the median was 0.60.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Shenzhen Salubris Pharmaceuticals Co Ltd is 0.91, which seems too high.

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

During the past 13 years, the highest Dividend Yield of Shenzhenlubris Pharmaceuticals Co was 4.60%. The lowest was 0.84%. And the median was 1.70%.

Good Sign:

Shenzhen Salubris Pharmaceuticals Co Ltd stock dividend yield is close to 3-year high.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shenzhenlubris Pharmaceuticals Co Dividends per Share Related Terms

Thank you for viewing the detailed overview of Shenzhenlubris Pharmaceuticals Co's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Shenzhenlubris Pharmaceuticals Co (SZSE:002294) Business Description

Traded in Other Exchanges
N/A
Address
1901 Chuangzhan Center, 6007 Shennan Road, Futian District, Shenzhen, CHN
Shenzhen Salubris Pharmaceuticals Co Ltd is a pharmaceutical company dedicated to the research, development, and sale of medical products for cardiovascular diseases, cephalous antibiotics, and bone resorption inhibitors. Its products mainly focused on the areas of cardio-cerebral vascular disease, diabetes, and complications, anti-tumor, and orthopedics, Its business lines include high-end chemical drugs, innovative biological drugs, and medical devices. Its businesses are located in China, the United States, Germany, France, and Japan, and other global countries and regions.
Executives
Yan Jie Directors, executives
Yang Jian Feng Secretary, Director
Zhao Song Ping Executives
Liu Jun Executives
Li Ai Zhen Supervisors
Chen Ping Executives
Ye Cheng Hai Director
Lu Feng Executives, directors
Chen Qiong Xing Supervisors
Li Ying Hui Supervisors
Pan Ling Man Independent director
Zhang Zhong Xing Executives

Shenzhenlubris Pharmaceuticals Co (SZSE:002294) Headlines

No Headlines